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ABStrAct
The purpose of this study was to determine the amount of caffeine in non-alcoholic energy drinks 
and prepared teas using reverse phase HPLC. Caffeine was extracted from 19 different types 
of non-alcoholic beverages and prepared teas sampled from supermarkets in Nairobi Central 
Business District, Kenya. These were analyzed alongside a caffeine standard of 99 % purity by 
use of HPLC-UV detector at the wavelength of 272nm, Supelco HS C18 column 25 cm x 4.6 
cm x 5 µm, oven temperature of 40 oC, mobile phase 80:20 (v/v) of methanol: water and mobile 
phase flow rate of 1.5mL/min. For quantitation purposes, serial dilution of the caffeine standard 
gave correlation coefficient (r) of 0.9993 and the retention time of 2.11±0.03 minute. Percentage 
recovery of caffeine from the column ranged from 89.78 to 105.59%. Limits of detection and 
quantitation were found to be 0.279 and 0.931 µg/mL respectively. It was found that Burn®, XL 
energy drink® and Red Bull® had the highest amount of caffeine. It was however noted that though 
most of the non-alcoholic beverages had high caffeine content they had no label claim.
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introDuction
Caffeine, the common name for 1, 3, 
7-trimethylxanthine, is the most widely used 
psychoactive drug in the world (Barone & Rob-
erts, 1996). Approximately 80% of the world’s 
population consumes it on a daily basis, and 
continuous research is being carried out to de-
termine its health benefits and consequences. 
The amount of caffeine consumed daily in foods 
and beverages varies widely. A typical cup of 
brewed coffee contains approximately 100mg 
of caffeine and a cup of green tea contains 20-
30mg of caffeine. Caffeine consumption from 
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all sources reaches 210-238mg/person per day in 
the USA and Canada and more than 400mg per 
person per day in Sweden and Finland (Klatsky 
et al., 1993; Barone & Roberts, 1996).
Caffeine acts as a mild central nervous sys-
tem stimulant (Chou & Bell, 2007), which is 
completely absorbed after ingestion within 30 to 
45 minutes and its effects substantially diminish 
within about 3 hours. Coffee, tea and soft drinks 
are the major sources of caffeine in the diets of 
US adults, with coffee being the primary and 
most potent source (Knight et al., 2004; Frary et 
al., 2005). Many over-the-counter medications, 
such as cold and allergy tablets, headache medi-
cines, diuretics, and stimulants also contain caf-
feine, although they lead to relatively minimal 
intake (Schreiber et al., 1988).
Caffeine is a central nervous system and 
metabolic stimulant (Nehling et al., 1992) and 
is used both recreationally and medically to re-
duce physical fatigue and restore mental alert-
ness when unusual weakness or drowsiness 
occurs. Caffeine stimulates the central nervous 
system first at the higher levels, resulting in in-
creased alertness and wakefulness, faster and 
clearer flow of thought, increased focus, and 
better general body coordination, and later at 
the spinal cord level at higher doses (Bolton 
& Gary, 1981).
Some researchers have however suggested 
several psychiatric syndromes that are associ-
ated with high caffeine consumption, among 
them anxiety disorders, diuretic effects, caf-
feine induced sleep disorder, caffeine intoxica-
tion, caffeine withdrawal, and caffeine depen-
dency syndrome (Winkelmayer et al., 2005). 
Caffeine has been associated with coronary 
heart disease (Yano et al., 1977), cardiovascu-
lar diseases (Dawber et al., 1974), hyperten-
sion and hypoglycemia (Watson & Kerr, 1999; 
Winkelmayer et al., 2005).
There is a growing individual desire to 
know the amount of caffeine consumed from 
non-alcoholic beverages. In epidemiological 
studies, it has been assumed that one cup of 
coffee contains at least 100 mg of caffeine, and 
soft drinks, such as colas, contain 10-50 mg 
of caffeine per 12-ounce serving (Christian & 
Brent, 2001).
Kenya is a major producer of coffee in Africa, 
and caffeine consumption is ranked second af-
ter tea in Kenya. Sources of caffeine consumed 
in Kenya range from packaged non-alcoholic 
beverages to over the counter caffeinated drugs. 
There is lack of information on the amount of 
caffeine consumed by an adult Kenyan in one 
serving of a mug of brewed coffee or a pack-
aged caffeinated soda. Many consumers of soft 
and energy drinks are totally unaware of caf-
feine content in these drinks. Similarly, com-
mercially available non-alcoholic beverages 
served in Kenya do not have product label on 
the packaging material and do not even declare 
caffeine as part of the ingredients.
In Kenya, the major source of caffeine is 
coffee. Kenyans consume only 3,000 tons of 
50, 000 tons of coffee grown in the country an-
nually (Douglas, 2009). However, the trend is 
changing with increase in coffee consumption 
in urban centers.
The present study determined the caffeine 
contents of commonly consumed non-alco-
holic drinks sold in supermarkets in Nairobi 
Kenya using reverse phase high performance 
liquid chromatography with UV/VIS detector.
MethoD
chemicals and Apparatus
A caffeine standard 99 % pure purchased 
from Prolabo, ECC, Manchester M, Discov-
ery® HS C-18 column 25 cm x 4.6mm x 5 µm 
Cat. No. 568523 from Supelco, Sigma-Aldrich 
Co. USA and analytical grade methanol of 
99.9% purity from Panreac Quimica SAU, 
Barcelona, and HPLC grade water Fischer 
Scientific were used.
The stocks solutions and the extracts were 
mixed in a sonicator (Bandelin, Sonorex RK 
255 transistor Berlin-German) and UV-Vis 
spectrophotometer (UV-1700, Pharmaspec 
Shimadzu, Tokyo Japan) was used to deter-
mine the wavelength of maximum absorption 
for caffeine. HPLC fitted with UV/VIS detec-
tor (Shimadzu Corporation, Kyoto Japan) was 
used for the determination of amount of caf-




A stock solution of 1.0mg/ml of caffeine 
was prepared by weighing 100 mg of caf-
feine into a 100ml volumetric flask. This was 
dissolved in distilled water to make up vol-
ume to 100mL. Working solution of 0.05mg/
mL, 0.1mg/mL, 0.5mg/mL were made by 
pipetting 5, 10 and 50mL of stock solution 
into a 100ml volumetric flask and topping 
up the volume to 100mL with HPLC analyti-
cal grade water. These serial dilutions of the 
standards were filtered using 0.45 µm mem-
brane filters and used in the construction of 
the calibration curve.
The mobile phase was prepared daily by 
mixing 80 volumes of methanol and 20 of 
HPLC water. This was then filtered under vac-
uum through 0.45µm pore size nylon filters 
and put in the HPLC mobile phase reservoir.
Sample Preparation
Nineteen samples of non-alcoholic energy 
drinks and prepared teas were degassed in a 
sonicator for 10 minutes and 5mL of each pi-
petted into a 100 mL amber flask and diluted 
20 times with mobile phase (methanol: water 
at 80:20 v/v). An aliquot of 2-5mL diluted 
sample was filtered through membrane filter of 
0.45µm pore diameter to remove any particu-
late matter. The filtrate was ready for determi-
nation of caffeine content by HPLC.
uV/Visible Spectra Scan for caffeine
Dilute caffeine standard stock solution was 
scanned at a range of 190 to 350nm wavelength 
with UV-Vis spectrophotometer (UV-1700, 
Pharmaspec Shimadzu, Tokyo Japan) to gen-
erate complete absorbance spectra and identify 
wavelength of maximum absorbance for sub-
sequent use in HPLC-UV/VIS detector.
Determination of caffeine content by 
hPlc-uV method
The HPLC column was conditioned for 20 
minutes with the mobile phase and the pro-
grammed oven temperature of 40oC before any 
analysis was carried out. HPLC-UV/VIS meth-
od was created with the following parameters, 
oven temperature of 40 oC, mobile phase flow 
rate of 1.5 mL/ minute, detector wavelength of 
272nm and injection volume of 20µL.
A blank sample composed of the extraction 
solution was injected severally until the base-
line was good. Then, serially diluted standards 
were injected in triplicates, and the retention 
time, peak areas and heights were recorded. 
After cleaning the system with blank solution, 
diluted sample was injected three times and the 
peak height and area with retention time corre-
sponding to that of the standard was recorded. 
The chromatograms for caffeine standard and 
a sample of Coca cola beverage are shown in 
Figures 1 and 2 respectively.
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figure 1. 10 ppm caffeine standards chromatogram, with retention time at 2.1 minutes
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reSultS
The wavelength of maximum absorbance 
for caffeine was found to be 272nm. This was 
then programmed in the HPLC-UV detector 
for the analysis of caffeine content in non-
alcoholic beverages and prepared teas. The 
mean retention time for caffeine was found 
to be 2.11 minutes with a standard deviation 
of ± 0.03 minutes. After analysis of the serial 
dilutions of the caffeine standard the coeffi-
cient of correlation was found to be 0.9993, 
and the equation of the linear regression was 
sufficiently fit for quantitative determination 
of caffeine in the samples. This is shown in 
Figure 3.
The limit of detection (LOD) and quantita-
tion (LOQ) of the analytes were determined 
based on the standard deviation of the detector 
response (α) and the slope (m) of the calibra-
tion curve. The following formulas were used; 
3α/m and 10α/m for LOD and LOQ respective-
ly (ISO 11843-2:2003). The limit of detection 
and quantitation of caffeine according to the 
method used were found to be 0.279 and 0.931 
µg/mL, respectively as shown in Table 1. 
figure 3. Linear regression curve for the serially diluted standards of caffeine




The limit of detection and quantitation of the 
method were determined by 3α/m and 10α/m, 
where α stands for standard deviation of the 
detector response and m is the slope of the 
linear regression curve. The detector response 
was obtained from 6 injections of 10ppm caf-
feine standard and then this concentration was 
divided by the average peak area. 
The ruggedness of the HPLC method was de-
termined by analysis of a known concentration 
of the standard working solution in the same 
chromatographic system and column on three 
different days. This is shown in Table 2. The pre-
pared mixture of standard was injected twelve 
times each day for a period of three days by the 
same analyst. The retention times and peak ar-
eas symmetry were found to be consistent dur-
ing the three days analysis with the 0.009% and 
0.302% relative standard deviations for the peak 
area and retention times respectively. The com-
parable detector responses obtained on different 
days indicate that the method is capable of pro-
ducing consistent data for routine analysis.
Analysis of 19 samples found that XL en-
ergy drink had the highest amount of caffeine 
with 98.06mg in a 250mL volume. This was 
closely followed by Burn which had 97.55mg 
per 250ml. The results for the other samples 
analyzed are as shown in Table 3. Tango or-
ange, 7UP and Rani Float were found not to 
contain caffeine.
DiScuSSion
Scientific literature is rich with a wide range 
of values for caffeine content in food products. 
In United States the following standard values 
are suggested by several authors, coffee (5 oz) 
85 mg for ground roasted coffee, 60 mg for 
instant and 3 mg for decaffeinated, 18 mg for 
instant colas. Caffeine consumption survey 
data are limited. In US approximately a mean 
daily caffeine intake for consumers is 4 mg/kg 
and among children younger than 18 years of 
age who are consumers of caffeine-containing 
foods, the mean daily caffeine intake is about 
1 mg/kg (Barrone & Roberts, 1996). 
Caffeine use is associated with several 
distinct psychiatric syndromes such as caf-
feine intoxication, withdrawal, dependence, 
caffeine-induced sleep disorder, and caffeine-
induced anxiety disorder. In certain people, 
caffeine consumption causes adverse health 
effects, such as anxiety, palpitations, irritabil-
ity, difficulty sleeping and stomach upsets. 
Other studies have indicated moderate caf-
feine intake could lower consumers’ risk of 
liver disease (Frary et al., 2005). The Ameri-
can Dietetic Association and the UK Food 
Standards Agency recommend not more 
than 300 mg of caffeine per day (Frary et al., 
2005). This recommendation is particularly 
useful to pregnant women who have greater 
table 1. Summary of precision and validation data for caffeine in non-alcoholic 
beverages obtained with reverse phase HPLC (n=12)
Validation Parameter Amount in (µg/ml)
Limit of detection (LOD) 0.279
Limit of quantitation (LOQ) 0.931
table 2. Day to day peak area and % recovery of 10ppm caffeine standard
number of days 1 2 3
*Mean Area ± SD 524112±3505 529257±4966 525715±3842 
Percent rSD 0.007 0.009 0.007
SD = standard deviation; RSD = relative standard deviation.
*Mean of 10ppm spectral peak areas for caffeine standard injected daily was used to monitor the reproducibility of 
the method. 
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risk of miscarriage or giving birth to low 
birth weight babies. 
Because of the health concerns associated 
with caffeine consumption, it is important that 
the manufacturers of caffeinated non-alcoholic 
beverages and teas append appropriate warn-
ing labels declaring presence and amount of 
caffeine. Studies show that 30 mgs or less of 
caffeine can alter self-reports of moods and 
affect behavior and 100 mg per day can lead 
to physical dependence and withdrawal symp-
toms upon abstinence.
Caffeine is an addictive drug, which alters 
the brain’s natural state and stimulates it in 
a manner similar to the amphetamines, co-
caine and heroin. One challenge with caffeine 
addiction is that most people don’t think of 
caffeine as a drug.
Determination of caffeine content in non-
alcoholic beverages and prepared teas is a very 
important analytical process to safeguard the 
well-being of the people who are vulnerable to 
the adverse effects of caffeine. 
concluSionS
Reverse phase high performance liquid 
chromatography method for determination of 
caffeine content in non-alcoholic beverages 
is simple, accurate and robust. The amount of 
caffeine in non-alcoholic beverages is critical 
especially when one what to control consump-
tion of caffeine. The data obtained in this study 
is important in the local setting because most 
of these non-alcoholic beverages list caffeine 
in their product label without withholding the 
amount contained. Therefore, one can easily 
control caffeine intake if caffeine is declared as 
an ingredient and at the same time the amount 
is indicated in the packaging materials.
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